stars 1 stars 2 stars 3

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013. Specialties: medicines, patients, pharmaceuticals, generics, specialty, branded, active pharmaceutical ingredients, quality, healthcare.

Teva Hungary Questions

The Teva Hungary annual revenue was $6.3 million in 2026.

Gabor Brodi is the OTC Business Unit Director of Teva Hungary.

3 people are employed at Teva Hungary.

Teva Hungary is based in Budapest, Budapest.

The NAICS codes for Teva Hungary are [54161, 54, 541612, 5416, 541].

The SIC codes for Teva Hungary are [736, 73].

Top Teva Hungary Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users